Kanagawa, Japan

Hajimu Kurumatani

USPTO Granted Patents = 16 

 


Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 98(Granted Patents)


Location History:

  • Kamakura, JP (1991 - 2016)
  • Fujisawa, JP (2017)
  • Kanagawa, JP (1997 - 2018)
  • Tokyo, JP (2018)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Hajimu Kurumatani: Innovator in Lipid Technology and Veterinary Medicine

Introduction

Hajimu Kurumatani is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the fields of lipid technology and veterinary medicine. With a total of 16 patents to his name, Kurumatani's work has the potential to impact both human health and animal care.

Latest Patents

Among his latest patents, Kurumatani has developed a carboxylic acid-type lipid that can enhance the adhesion and aggregation of platelets. This innovation is noteworthy because it functions effectively even without the presence of proteins or peptides typically involved in these processes. Additionally, he has created a therapeutic method for cats suffering from chronic kidney disease. This method aims to inhibit the progression of the disease and improve the overall survival rate of affected cats.

Career Highlights

Throughout his career, Hajimu Kurumatani has worked with notable companies such as Toray Industries, Inc. and Nanotheta Co., Ltd. His experience in these organizations has allowed him to refine his expertise in lipid technology and therapeutic applications.

Collaborations

Kurumatani has collaborated with esteemed colleagues, including Ayako Kawashima and Masafumi Isogaya. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Hajimu Kurumatani's contributions to lipid technology and veterinary medicine exemplify the impact of innovative thinking in addressing health challenges. His patents and collaborative efforts continue to pave the way for advancements in these critical fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…